• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在马萨诸塞州 COVID-19 大流行期间，SARS-CoV-2 疫苗接种与感染风险的差异。

Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts.

机构信息

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

出版信息

JAMA Health Forum. 2021 Sep 17;2(9):e212666. doi: 10.1001/jamahealthforum.2021.2666. eCollection 2021 Sep.

DOI:10.1001/jamahealthforum.2021.2666
PMID:35977180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8796904/
Abstract

This cohort study examines the alignment of vaccination and SARS-CoV-2 risk in Massachusetts by creating and applying a vaccination-to-infection risk ratio.

摘要

本队列研究通过创建和应用疫苗接种与感染风险比，考察了马萨诸塞州疫苗接种与 SARS-CoV-2 风险的一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0683/8796904/b341343cd28a/jamahealthforum-e212666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0683/8796904/a7e415b1ad8f/jamahealthforum-e212666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0683/8796904/b341343cd28a/jamahealthforum-e212666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0683/8796904/a7e415b1ad8f/jamahealthforum-e212666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0683/8796904/b341343cd28a/jamahealthforum-e212666-g002.jpg

相似文献

1
Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts.在马萨诸塞州 COVID-19 大流行期间，SARS-CoV-2 疫苗接种与感染风险的差异。
JAMA Health Forum. 2021 Sep 17;2(9):e212666. doi: 10.1001/jamahealthforum.2021.2666. eCollection 2021 Sep.
2
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.健康受试者对 mRNA COVID-19 疫苗的抗体反应差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0034121. doi: 10.1128/Spectrum.00341-21. Epub 2021 Aug 4.
3
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.代表 COVID-19 的慕尼黑队列（KoCo19）：从大流行开始到德尔塔病毒变异。
BMC Infect Dis. 2023 Jul 13;23(1):466. doi: 10.1186/s12879-023-08435-1.
4
The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.辉瑞 COVID-19 疫苗接种后日本国立感染症研究所-国立卫生研究所员工的保护性疫苗接种后抗体水平。
Przegl Epidemiol. 2021;75(1):3-13. doi: 10.32394/pe.75.01.
5
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.一种基于鼻腔内的 OMV 疫苗可诱导针对 SARS-CoV-2 感染的高黏膜和全身保护免疫。
Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021.
6
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.2021 年 5 月波兰人群中对 SARS-CoV-2 具有免疫力的隐匿人群。
PLoS One. 2022 Feb 3;17(2):e0253638. doi: 10.1371/journal.pone.0253638. eCollection 2022.
7
Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece.与接种第二剂 BNT162b2 疫苗后 3 个月抗 SARS-CoV-2 抗体滴度相关的因素：希腊西部的一项纵向观察性队列研究。
BMJ Open. 2022 May 19;12(5):e057084. doi: 10.1136/bmjopen-2021-057084.
8
Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.评估 MERS-CoV 感染和 SARS-CoV-2 疫苗接种患者中的广谱反应。
JAMA Netw Open. 2023 Jun 1;6(6):e2319222. doi: 10.1001/jamanetworkopen.2023.19222.
9
Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases: A Longitudinal Analysis.COVID-19 大流行开始时对 SARS-CoV-2 的感知风险以及随后风湿性疾病患者的疫苗接种态度：一项纵向分析。
J Clin Rheumatol. 2022 Jun 1;28(4):190-195. doi: 10.1097/RHU.0000000000001826. Epub 2022 Jan 24.
10
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.一项在已接种 SARS-CoV-2 疫苗的≥75 岁成年人中评估不同 COVID-19 疫苗免疫原性和反应原性的多国、2 期、随机、自适应方案：在 VACCELERATE 网络内开展的一项试验。
Trials. 2022 Oct 8;23(1):865. doi: 10.1186/s13063-022-06791-y.

引用本文的文献

1
Spatial Accessibility and Uptake of Pediatric COVID-19 Vaccinations by Social Vulnerability.社会脆弱性视角下的儿童 COVID-19 疫苗接种的可达性和接受度。
Pediatrics. 2024 Aug 1;154(2). doi: 10.1542/peds.2024-065938.
2
School-Based Mobile Clinics to Improve Vaccine Access: A Cross-sectional Study of COVID-19 Vaccination.以学校为基础的移动诊所改善疫苗接种可及性：一项关于新冠疫苗接种的横断面研究
J Pediatric Infect Dis Soc. 2024 May 30;13(5):274-275. doi: 10.1093/jpids/piae032.
3
Social determinants of health and vaccine uptake during the first wave of the COVID-19 pandemic: A systematic review.

本文引用的文献

1
Taking Vaccine to Where the Virus Is-Equity and Effectiveness in Coronavirus Vaccinations.将疫苗带到病毒所在之处——新冠疫苗接种的公平性与有效性
JAMA Health Forum. 2021 Feb 1;2(2):e210213. doi: 10.1001/jamahealthforum.2021.0213.
2
Vaccine Hesitancy Is a Scapegoat for Structural Racism.疫苗犹豫是结构性种族主义的替罪羊。
JAMA Health Forum. 2021 Mar 1;2(3):e210434. doi: 10.1001/jamahealthforum.2021.0434.
3
Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone.
新冠疫情第一波期间健康的社会决定因素与疫苗接种情况：一项系统综述
Prev Med Rep. 2023 Jul 16;35:102319. doi: 10.1016/j.pmedr.2023.102319. eCollection 2023 Oct.
4
Mapping Changes in Inequities in COVID-19 Vaccinations Relative to Deaths in Chicago, Illinois.绘制伊利诺伊州芝加哥市新冠疫苗接种不平等现象相对于死亡情况的变化
Prev Chronic Dis. 2023 Apr 27;20:E32. doi: 10.5888/pcd20.220319.
5
Erratum: Error in Results and Additional Information Section Added to End Matter.勘误：结果部分的错误及补充信息已添加到文末。
JAMA Health Forum. 2021 Nov 5;2(11):e213871. doi: 10.1001/jamahealthforum.2021.3871. eCollection 2021 Nov.
与仅基于年龄阈值的方式相比，针对地理区域的新冠疫苗接种更为公平，且能避免更多死亡。
Sci Adv. 2021 Oct;7(40):eabj2099. doi: 10.1126/sciadv.abj2099. Epub 2021 Sep 29.
4
Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.大规模疫苗接种点——遏制新冠疫情的一项重要创新举措。
N Engl J Med. 2021 May 6;384(18):e67. doi: 10.1056/NEJMp2102535. Epub 2021 Mar 10.
5
Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing.利用洛伦兹曲线衡量 COVID-19 检测中的种族不平等。
JAMA Netw Open. 2021 Jan 4;4(1):e2032696. doi: 10.1001/jamanetworkopen.2020.32696.
6
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.2017 年第四季度美国暴露前预防用药的使用情况和暴露前预防用药的需求比。
Ann Epidemiol. 2018 Dec;28(12):841-849. doi: 10.1016/j.annepidem.2018.06.005. Epub 2018 Jun 15.